Bio-Rad Laboratories Inc.

NYSE: BIO · Real-Time Price · USD
285.79
-1.42 (-0.49%)
At close: Aug 15, 2025, 3:59 PM
285.66
-0.05%
After-hours: Aug 15, 2025, 05:36 PM EDT

Bio-Rad Laboratories Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-118.7M -2.16B -1.84B -778.7M -1.33B -322.4M -637.3M -153.5M -422.6M -185.5M -3.62B -6.03B -1.94B -98.8M 4.25B 6.66B 4.05B 4.1B
Depreciation & Amortization
88.2M 162.7M 161.7M 149.6M 148M 147.4M 145.9M 148.7M 145.7M 144M 141.8M 135.5M 134.9M 134.5M 133.8M 136.3M 136.2M 137.2M
Stock-Based Compensation
32M 62.3M 62.3M 62.1M 62.4M 60M 61.3M 63.2M 63M 64M 60.9M 57.8M 55.2M 53M 51.2M 48.5M 46.2M 43.6M
Other Working Capital
269.05M -406.95M -331.65M -414M -609.5M -259.3M -346.1M -97.8M -211.8M -231.3M -1.27B -2.02B -851.5M -315.4M 1.05B 1.8B 1.07B 1.14B
Other Non-Cash Items
255.01M 2.81B 2.42B 1.39B 2.1B 800.12M 1.24B 601.82M 957.33M 704.13M 5.23B 8.34B 3.18B 808M -4.92B -7.97B -4.69B -4.85B
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
277.65M -358.25M -347.85M -413M -636.2M -338.5M -432.8M -275.9M -445.8M -473.8M -1.61B -2.23B -939.8M -303.3M 1.14B 1.91B 1.15B 1.2B
Operating Cash Flow
534.16M 515.31M 455.2M 412.1M 346.2M 346.62M 374.94M 384.32M 297.63M 252.84M 205.21M 272.71M 492.05M 593.4M 656.52M 783.33M 688.63M 626.13M
Capital Expenditures
-186.64M -183.22M -189M -188.34M -168.77M -161.13M -156.68M -161.37M -144.87M -127.57M -124.92M -121.23M -128.28M -134.33M -120.8M -116.7M -102.05M -96.78M
Cash Acquisitions
n/a n/a n/a 2.5M 2.5M 2.5M 2.5M n/a -100.75M -100.75M -100.75M -226.26M -125.52M -125.52M -125.52M 96.66M 96.89M 12.24M
Purchase of Investments
-928.66M -1.02B -1.28B -1.21B -1B -891.91M -689.04M -790.63M -923.33M -1.3B -2.06B -2.65B -2.53B -2.19B -1.31B -620.51M -427.73M -321.89M
Sales Maturities Of Investments
1.13B 1.09B 1.31B 1.33B 1.16B 1.1B 863.22M 830.54M 968.63M 1.16B 1.07B 1.29B 1.08B 798.64M 766.9M 357M 321.56M 306.81M
Other Investing Acitivies
-239.99M -23.33M -23.3M -23.15M 264K 237K 211K -1.22M -1.28M 146K 146K 1.47M 1.51M 40K 52K 3.48M 3.46M 3.46M
Investing Cash Flow
-198.68M -114.21M -160.2M -57.46M -11.32M 47.59M 20.21M -121.3M -200.22M -372.69M -1.22B -1.7B -1.7B -1.65B -784.44M -280.06M -107.86M -96.16M
Debt Repayment
-264K -382K -400K -477K -472K -470K -467K -492K -487K -521K 1.19B 1.18B 1.18B 1.18B -3.02M -426.8M -426.86M -426.92M
Common Stock Repurchased
-339.95M -300.75M -203.6M -403.59M -327.07M -433.48M -428.73M -319.41M -298.09M -215.68M -215.68M -125M -125M n/a -50M -50M -50M -50M
Dividend Paid
-48.9M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
32.88M -15.39M -14.8M 10.89M 3.76M 4.01M 3.55M 8.25M 4.75M 3.79M 3.54M 5.35M -1.45M -2.29M -2.41M -5.15M 10.93M 5.15M
Financial Cash Flow
-356.23M -316.52M -218.8M -393.17M -323.78M -429.94M -425.65M -311.65M -293.82M -212.41M 973.58M 1.06B 1.06B 1.18B -55.43M -481.95M -465.93M -471.77M
Net Cash Flow
-36.02M 89.35M 85.43M -46.13M 17.23M -30.75M -30.18M -59.93M -206.43M -338.15M -36.59M -346.28M -140.25M 124.95M -195.98M 19.42M 125.03M 69.26M
Free Cash Flow
347.52M 332.08M 266.2M 223.75M 177.42M 185.49M 218.26M 222.95M 152.76M 125.27M 80.29M 151.49M 363.77M 459.07M 535.72M 666.63M 586.58M 529.35M